[latest]
-
Novo Nordisk confident of amycretin obesity drug launch this decade
-
US household wealth soars to record on booming stocks
-
Novo valuation surpasses Tesla on experimental obesity drug data
-
Fed’s Powell: “Not far” from confidence needed to cut rates
-
Powell says Fed not “remotely close” to a central bank digital currency
-
Boeing discloses names of 737 MAX employees after NTSB chair faults cooperation
-
After Trump meet, Musk says he won’t donate to either US presidential candidate
-
House lawmaker says US ByteDance investors should urge China to allow TikTok sale
-
Institutional investors may help bitcoin sustain new heights
-
Apple tweaks changes to comply with EU tech rules after criticism